Literature DB >> 16264081

Responses to written notification during out-of-hospital care trials using waiver of informed consent.

Julia M Spence1, Vincenza Notarangelo, Jamie Frank, Jennifer Long, Laurie J Morrison.   

Abstract

BACKGROUND: Resuscitation research has been allowed to proceed using waiver of consent when compliance with guidelines is assured. In these circumstances, institutional review boards (IRBs) may request notification of enrolled patients.
OBJECTIVES: To describe the notification process developed with IRB feedback and implemented in two out-of-hospital randomized controlled trials (RCTs) in a large urban setting.
METHODS: This was a descriptive review of two RCTs recruiting a total of 620 patients: the Out-of-hospital Cardiac Arrest Rectilinear Biphasic to Monophasic Damped Sine Defibrillation Waveforms with Advanced Life Support Intervention Trial (ORBIT), which compared rectilinear biphasic and monophasic damped sine waveform for out-of-hospital cardiac arrest, and the Prehospital Pacing versus Conventional Treatment Effectiveness Trial (PrePACE), which compared dopamine and transcutaneous pacing for unstable bradycardia.
RESULTS: The ORBIT study enrolled 538 patients. In 44 (8%) patients, contact information could not be obtained. Notification was attempted for 494 (92%) patients; 48 (10%) letters were returned to sender. Researchers were contacted by telephone regarding 37 (8%) subjects: 16 (43%) requested information, 14 (38%) responded positively, and one (3%) did not return follow-up calls. Overall, two (0.4%) were withdrawn from the study. The PrePACE study enrolled 82 subjects. Contact information was unavailable for one (1%). For the remaining 81 patients, four (5%) letters were returned to sender. Researchers were contacted regarding ten (13%) subjects: seven (70%) requested information, two (20%) responded positively, and one (10%) did not return follow-up calls. No patient was withdrawn from the study.
CONCLUSIONS: Contact information may be difficult to obtain for up to 20% of out-of-hospital critical patients. In 8% to 13% of cases, patients or designates contacted researchers; most feedback was positive. Frequently, non-study-related information was requested, consuming significant resources. Using this method, fewer than 1% of patients were withdrawn from the studies.

Entities:  

Mesh:

Year:  2005        PMID: 16264081     DOI: 10.1197/j.aem.2005.06.009

Source DB:  PubMed          Journal:  Acad Emerg Med        ISSN: 1069-6563            Impact factor:   3.451


  3 in total

Review 1.  Exceptions to the rule of informed consent for research with an intervention.

Authors:  Susanne Rebers; Neil K Aaronson; Flora E van Leeuwen; Marjanka K Schmidt
Journal:  BMC Med Ethics       Date:  2016-02-06       Impact factor: 2.652

2.  Deferred consent in emergency intensive care research: what if the patient dies early? Use the data or not?

Authors:  T C Jansen; E J O Kompanje; C Druml; D K Menon; C J Wiedermann; J Bakker
Journal:  Intensive Care Med       Date:  2007-03-07       Impact factor: 17.440

3.  A randomized controlled feasibility trial comparing safety and effectiveness of prehospital pacing versus conventional treatment: 'PrePACE'.

Authors:  Laurie J Morrison; Jennifer Long; Marian Vermeulen; Brian Schwartz; Bruce Sawadsky; Jamie Frank; Bruce Cameron; Robert Burgess; Jennifer Shield; Paul Bagley; Vivien Mausz; James E Brewer; Paul Dorian
Journal:  Resuscitation       Date:  2007-10-22       Impact factor: 5.262

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.